Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease
about
GIS and Remote Sensing Use in the Exploration of Lyme Disease EpidemiologyBlocking pathogen transmission at the source: reservoir targeted OspA-based vaccines against Borrelia burgdorferi.Vaccination against Lyme disease: past, present, and futureSylvatic plague vaccine: a new tool for conservation of threatened and endangered species?Broad diversity of host responses of the white-footed mouse Peromyscus leucopus to Borrelia infection and antigens.Oral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection.Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector.Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission.Live Attenuated Borrelia burgdorferi Targeted Mutants in an Infectious Strain Background Protect Mice from Challenge InfectionImmunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against lyme disease.RNAi reveals proteins for metabolism and protein processing associated with Langat virus infection in Ixodes scapularis (black-legged tick) ISE6 cells.Oral vaccination with vaccinia virus expressing the tick antigen subolesin inhibits tick feeding and transmission of Borrelia burgdorferiInfection resistance and tolerance in Peromyscus spp., natural reservoirs of microbes that are virulent for humans.Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release.Sylvatic Plague Vaccine Partially Protects Prairie Dogs (Cynomys spp.) in Field Trials.Report from the field: Overview of the Sixth Annual Vaccine Renaissance Conference
P2860
Q26775046-AE3C8A72-D6D4-49B8-A663-200B6546C1D4Q34249814-E4FC8B65-DC4D-4E94-A58F-5C2AEC674736Q34327726-AF16593B-0C4A-40B2-A87E-06EA5485D9ACQ34357131-C14085A8-2932-4D87-87FE-BFF0C91F68F7Q35858600-8E9481EA-0E3B-48A3-9239-28D7EB28B263Q35962468-7DB5582A-1FCD-4A64-A7B0-B00C85760076Q36588072-5C400230-BC83-4B39-B84C-255BDDC45D9BQ36723429-E7257D50-4D0B-44A0-9154-D46C09C4C8B8Q37163689-978F5DBB-BCCC-40D5-BCBE-ED155D41CA06Q37558373-D5DF1C59-0731-4CAE-BC81-E7302C3E67CEQ37586516-5BBBADFC-3F53-4168-B531-5FF19B0B2321Q37610717-6FEC01F7-D8CF-4414-81F3-BEAA5F5306B2Q38887160-A567F2D7-5A93-4207-861E-BA759B8F496EQ40583822-FF325007-A8E5-4451-B761-9CFFCBAFD13DQ41357837-F8E6CB48-054B-41ED-8436-B731A2B9770FQ42379418-2102D868-D9D6-4A6A-9B8A-DE83FBA669B3
P2860
Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Development of a baited oral v ...... trategies against Lyme disease
@ast
Development of a baited oral v ...... trategies against Lyme disease
@en
type
label
Development of a baited oral v ...... trategies against Lyme disease
@ast
Development of a baited oral v ...... trategies against Lyme disease
@en
prefLabel
Development of a baited oral v ...... trategies against Lyme disease
@ast
Development of a baited oral v ...... trategies against Lyme disease
@en
P2093
P2860
P1433
P1476
Development of a baited oral v ...... trategies against Lyme disease
@en
P2093
Debaditya Bhattacharya
Gary Luker
Linden T Hu
Mekki Bensaci
Sam R Telford
Steven Wisdom
P2860
P304
P356
10.1016/J.VACCINE.2011.07.100
P407
P577
2011-08-02T00:00:00Z